Patients with a clinical diagnosis of PAH and with BMPR2 or biallelic EIF2AK4 variants presented with symptoms at the age of 25.57 ± 10.17 years and 31.6 ± 9.38 years, respectively. Here, EIF2AK4 is linked to pulmonary arterial hypertension.